"The integration of AI and mechanistic modeling in drug development shows promise but is still in its infancy," explains Jim Shen, Bristol Myers Squibb, on the BioTalk Unzipped #podcast. Dr. Shen, an AAPS Community leader, will discuss #AI at #PharmSci360 in October.